Investment analysts at Goldman Sachs Group, Inc. (The) initiated coverage on shares of Waters Corporation (NYSE:WAT) in a research report issued to clients and investors on Tuesday. The firm set a “hold” rating and a $180.00 price target on the medical instruments supplier’s stock. Goldman Sachs Group, Inc. (The)’s price objective points to a potential upside of 0.57% from the company’s previous close.

Other equities research analysts have also recently issued research reports about the company. Zacks Investment Research raised Waters Corporation from a “hold” rating to a “buy” rating and set a $202.00 target price on the stock in a report on Thursday, July 13th. BidaskClub cut Waters Corporation from a “strong-buy” rating to a “buy” rating in a report on Friday, July 28th. Jefferies Group LLC reissued a “hold” rating and set a $175.00 target price on shares of Waters Corporation in a report on Thursday, July 27th. Deutsche Bank AG cut Waters Corporation from a “buy” rating to a “hold” rating and boosted their target price for the stock from $183.00 to $194.00 in a report on Monday, July 10th. Finally, Cowen and Company reissued a “hold” rating and set a $190.00 target price on shares of Waters Corporation in a report on Friday, July 14th. Two research analysts have rated the stock with a sell rating, six have issued a hold rating, six have assigned a buy rating and one has issued a strong buy rating to the company. The stock presently has a consensus rating of “Hold” and a consensus price target of $185.50.

Shares of Waters Corporation (NYSE WAT) opened at 178.74 on Tuesday. The firm has a market cap of $14.27 billion, a PE ratio of 26.94 and a beta of 0.83. Waters Corporation has a 12-month low of $133.35 and a 12-month high of $190.39. The company has a 50 day moving average price of $181.80 and a 200-day moving average price of $174.21.

Waters Corporation (NYSE:WAT) last announced its earnings results on Tuesday, July 25th. The medical instruments supplier reported $1.76 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $1.71 by $0.05. Waters Corporation had a return on equity of 23.91% and a net margin of 24.26%. The firm had revenue of $558.30 million for the quarter, compared to analysts’ expectations of $553.22 million. During the same quarter in the previous year, the company earned $1.58 earnings per share. The firm’s quarterly revenue was up 4.0% compared to the same quarter last year. Analysts expect that Waters Corporation will post $7.39 EPS for the current year.

TRADEMARK VIOLATION WARNING: “Goldman Sachs Group, Inc. (The) Initiates Coverage on Waters Corporation (WAT)” was posted by The Cerbat Gem and is the property of of The Cerbat Gem. If you are viewing this article on another website, it was stolen and republished in violation of US & international copyright and trademark laws. The original version of this article can be read at https://www.thecerbatgem.com/2017/09/28/goldman-sachs-group-inc-the-initiates-coverage-on-waters-corporation-wat.html.

In other Waters Corporation news, SVP Rohit Khanna sold 18,400 shares of Waters Corporation stock in a transaction that occurred on Friday, September 8th. The shares were sold at an average price of $185.78, for a total transaction of $3,418,352.00. Following the transaction, the senior vice president now directly owns 22,477 shares in the company, valued at approximately $4,175,777.06. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, Director Christopher A. Kuebler sold 3,500 shares of Waters Corporation stock in a transaction that occurred on Tuesday, August 8th. The stock was sold at an average price of $179.67, for a total transaction of $628,845.00. Following the transaction, the director now owns 17,849 shares in the company, valued at $3,206,929.83. The disclosure for this sale can be found here. 5.07% of the stock is currently owned by corporate insiders.

Hedge funds and other institutional investors have recently bought and sold shares of the business. UBS Asset Management Americas Inc. grew its position in Waters Corporation by 46.7% during the 2nd quarter. UBS Asset Management Americas Inc. now owns 374,472 shares of the medical instruments supplier’s stock worth $68,843,000 after purchasing an additional 119,130 shares in the last quarter. Aviva PLC grew its position in Waters Corporation by 0.9% during the 2nd quarter. Aviva PLC now owns 47,903 shares of the medical instruments supplier’s stock worth $8,806,000 after purchasing an additional 420 shares in the last quarter. Chicago Equity Partners LLC purchased a new position in Waters Corporation during the 2nd quarter worth approximately $3,230,000. TIAA CREF Investment Management LLC grew its position in Waters Corporation by 42.7% during the 1st quarter. TIAA CREF Investment Management LLC now owns 375,413 shares of the medical instruments supplier’s stock worth $58,681,000 after purchasing an additional 112,335 shares in the last quarter. Finally, Schwab Charles Investment Management Inc. grew its position in Waters Corporation by 6.5% during the 2nd quarter. Schwab Charles Investment Management Inc. now owns 263,764 shares of the medical instruments supplier’s stock worth $48,491,000 after purchasing an additional 16,108 shares in the last quarter. Hedge funds and other institutional investors own 91.00% of the company’s stock.

About Waters Corporation

Waters Corporation is an analytical instrument manufacturer. The Company operates through two segments: Waters and TA. It designs, manufactures, sells and services high performance liquid chromatography (HPLC), ultra performance liquid chromatography (UPLC and together with HPLC, referred to as LC) and mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products and post-warranty service plans.

Analyst Recommendations for Waters Corporation (NYSE:WAT)

Receive News & Stock Ratings for Waters Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waters Corporation and related stocks with our FREE daily email newsletter.